Cases change after the first report, and the clock follows the information:
- New medically relevant information on a reported case starts a new day 0 for the follow-up report (ICH E2D(R1)). The FDA wants follow-ups to 15-day Alert reports within 15 calendar days of receiving the new information, and if information cannot be obtained, records of the attempts (21 CFR 314.80).
- A case first classed as non-serious that turns serious with follow-up qualifies for expedited reporting, with day 0 on the date of the follow-up.
- A case sent as serious that becomes non-serious after follow-up: GVP VI says that information still goes within 15 days; later follow-ups then use the non-serious timeline.
- An amendment with no new information, such as a correction after internal quality review, gets no new day 0.
GVP VI calls follow-up significant when it could change the assessment or the management of the case, or its seriousness (new lab results, a new outcome, a new suspect drug). Updated comments or corrected typing errors are non-significant.